SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006213
Filing Date
2021-05-06
Accepted
2021-05-06 16:10:39
Documents
92
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20210331x10q.htm   iXBRL 10-Q 1936996
2 EX-31.1 irwd-20210331xex31d1.htm EX-31.1 16938
3 EX-31.2 irwd-20210331xex31d2.htm EX-31.2 16975
4 EX-32.1 irwd-20210331xex32d1.htm EX-32.1 8079
5 EX-32.2 irwd-20210331xex32d2.htm EX-32.2 8055
  Complete submission text file 0001558370-21-006213.txt   8704252

Data Files

Seq Description Document Type Size
6 EX-101.SCH irwd-20210331.xsd EX-101.SCH 70033
7 EX-101.CAL irwd-20210331_cal.xml EX-101.CAL 68324
8 EX-101.DEF irwd-20210331_def.xml EX-101.DEF 301610
9 EX-101.LAB irwd-20210331_lab.xml EX-101.LAB 563545
10 EX-101.PRE irwd-20210331_pre.xml EX-101.PRE 526140
11 EXTRACTED XBRL INSTANCE DOCUMENT irwd-20210331x10q_htm.xml XML 1487256
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 21897838
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences